I am a
Home I AM A Search Login

Papers of the Week

2020 May

Isr Med Assoc J



The Effects of Adalimumab in Behçet Disease Patients on Clinical Manifestations and on Pro-Inflammatory Cytokines Milieu: Long-Term Follow-Up.


Braun-Moscovici Y, Tavor Y, Markovits D, Toledano K, Rozin A, Nahir MA, Balbir-Gurman A
Isr Med Assoc J. 2020 May; 22(5):289-293.
PMID: 32378820.


Behçet's disease is a multi-systemic chronic relapsing inflammatory disease, classified among the vasculitides. The heterogeneity of clinical manifestations challenges the disease management.